352 related articles for article (PubMed ID: 12471615)
41. Expression of follicle-stimulating hormone receptor (FSHR), protein kinase B-2 (AKT2) and adapter protein with PH domain, PTB domain, and leucine zipper (APPL1) in pig ovaries.
Zhou N; Wang N; Qin X; Liu Q; Wang J; Dong H; Zhou J; Fang F
Pol J Vet Sci; 2017 Dec; 20(4):661-667. PubMed ID: 29611645
[TBL] [Abstract][Full Text] [Related]
42. Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway.
Zhang Z; Zhu Y; Lai Y; Wu X; Feng Z; Yu Y; Bast RC; Wan X; Xi X; Feng Y
Int J Oncol; 2013 Oct; 43(4):1194-204. PubMed ID: 23921511
[TBL] [Abstract][Full Text] [Related]
43. Expression Levels of Follicle-Stimulating Hormone Receptor and Implication in Diagnostic and Therapeutic Strategy of Ovarian Cancer.
Wei S; Lai L; Yang J; Zhuandi G
Oncol Res Treat; 2018; 41(10):651-654. PubMed ID: 30145593
[TBL] [Abstract][Full Text] [Related]
44. Characterization and clinical significance of the CADM1/HER2/STAT3 axis in serous ovarian tumors.
Wu D; Lei Y; Liu Q; Hu H; Li H; Xie L; Zhou J
Medicine (Baltimore); 2021 Feb; 100(8):e23777. PubMed ID: 33663040
[TBL] [Abstract][Full Text] [Related]
45. Follicle-Stimulating Hormone Receptor (FSHR): A Promising Tool in Oncology?
Papadimitriou K; Kountourakis P; Kottorou AE; Antonacopoulou AG; Rolfo C; Peeters M; Kalofonos HP
Mol Diagn Ther; 2016 Dec; 20(6):523-530. PubMed ID: 27392476
[TBL] [Abstract][Full Text] [Related]
46. Low-grade Serous Neoplasia of the Female Genital Tract.
Folkins AK; Longacre TA
Surg Pathol Clin; 2019 Jun; 12(2):481-513. PubMed ID: 31097112
[TBL] [Abstract][Full Text] [Related]
47. Cloning and expression analysis of the follicle-stimulating hormone receptor (FSHR) gene in the reproductive axis of female yaks (Bos grunniens).
Xia Y; Wang Q; He XD; Chen Y; JiGe MT; Zi XD
Domest Anim Endocrinol; 2020 Jan; 70():106383. PubMed ID: 31479928
[TBL] [Abstract][Full Text] [Related]
48. A novel follicle-stimulating hormone receptor mutation causing primary ovarian failure: a fertility application of whole exome sequencing.
Bramble MS; Goldstein EH; Lipson A; Ngun T; Eskin A; Gosschalk JE; Roach L; Vashist N; Barseghyan H; Lee E; Arboleda VA; Vaiman D; Yuksel Z; Fellous M; Vilain E
Hum Reprod; 2016 Apr; 31(4):905-14. PubMed ID: 26911863
[TBL] [Abstract][Full Text] [Related]
49. The FSHR G-29A variant is not associated with the ovarian response to exogenous FSH stimulation.
Song D; Hong L; Zhang ZF; Xu JH; Zhang HQ; Huang XL; Du J
Am J Reprod Immunol; 2021 Dec; 86(6):e13500. PubMed ID: 34558137
[TBL] [Abstract][Full Text] [Related]
50. [Pitfalls and common problems in the differential diagnosis of epithelial ovarian tumors].
Lax SF
Pathologe; 2019 Feb; 40(1):46-60. PubMed ID: 30719693
[TBL] [Abstract][Full Text] [Related]
51. Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target.
Perales-Puchalt A; Svoronos N; Rutkowski MR; Allegrezza MJ; Tesone AJ; Payne KK; Wickramasinghe J; Nguyen JM; O'Brien SW; Gumireddy K; Huang Q; Cadungog MG; Connolly DC; Tchou J; Curiel TJ; Conejo-Garcia JR
Clin Cancer Res; 2017 Jan; 23(2):441-453. PubMed ID: 27435394
[TBL] [Abstract][Full Text] [Related]
52. Upregulated CDK16 Expression in Serous Epithelial Ovarian Cancer Cells.
Zhou Q; Yu Y
Med Sci Monit; 2015 Nov; 21():3409-14. PubMed ID: 26546806
[TBL] [Abstract][Full Text] [Related]
53. PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis.
Wang H; Li G; Yin Y; Wang J; Wang H; Wei W; Guo Q; Ma H; Shi Q; Zhou X; Wang J
Int J Clin Exp Pathol; 2014; 7(11):7881-9. PubMed ID: 25550828
[TBL] [Abstract][Full Text] [Related]
54. Granulosa Cell-Specific Brca1 Loss Alone or Combined with Trp53 Haploinsufficiency and Transgenic FSH Expression Fails to Induce Ovarian Tumors.
Upton DH; Fuller ES; Colvin EK; Walters KA; Jimenez M; Desai R; Handelsman DJ; Howell VM; Allan CM
Horm Cancer; 2015 Aug; 6(4):142-52. PubMed ID: 25943777
[TBL] [Abstract][Full Text] [Related]
55. Follicle-stimulating hormone promotes nerve growth factor and vascular endothelial growth factor expression in epithelial ovarian cells.
Garrido MP; Bruneau N; Vega M; Selman A; Tapia JC; Romero C
Histol Histopathol; 2020 Sep; 35(9):961-971. PubMed ID: 32369181
[TBL] [Abstract][Full Text] [Related]
56. Frequent and increased expression of human METCAM/MUC18 in cancer tissues and metastatic lesions is associated with the clinical progression of human ovarian carcinoma.
Wu GJ; Dickerson EB
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):509-17. PubMed ID: 25510693
[TBL] [Abstract][Full Text] [Related]
57. [Expression and role of glucose-regulated protein 78 in ovarian serous adenocarcinoma].
Fan LM; Su J; Dong H; Wei M; Cui MH
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(9):659-62. PubMed ID: 23751742
[TBL] [Abstract][Full Text] [Related]
58. Functional Expression of FSH Receptor in Endometriotic Lesions.
Ponikwicka-Tyszko D; Chrusciel M; Stelmaszewska J; Bernaczyk P; Sztachelska M; Sidorkiewicz I; Doroszko M; Tomaszewski J; Tapanainen JS; Huhtaniemi I; Wolczynski S; Rahman NA
J Clin Endocrinol Metab; 2016 Jul; 101(7):2905-14. PubMed ID: 27224263
[TBL] [Abstract][Full Text] [Related]
59. Low-grade serous tumors of ovary.
Bell DA
Int J Gynecol Pathol; 2014 Jul; 33(4):348-56. PubMed ID: 24901394
[TBL] [Abstract][Full Text] [Related]
60. Reduced CMTM5 expression correlates with carcinogenesis in human epithelial ovarian cancer.
Li P; Liu K; Li L; Yang M; Gao W; Feng J; Lv Y; Qu X; Kong B
Int J Gynecol Cancer; 2011 Oct; 21(7):1248-55. PubMed ID: 21841490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
